Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $171.7M | $217.1M | $233.2M | $259.9M | $260.0M | $297.7M | $471.9M | $361.7M |
| Cost of revenue | $51.1M | $65.0M | $70.2M | $76.7M | $79.8M | $85.9M | $165.7M | $91.2M |
| Gross profit | $120.5M | $152.1M | $163.0M | $183.2M | $180.2M | $211.8M | $306.3M | $270.5M |
| Gross margin | 70.2% | 70.1% | 69.9% | 70.5% | 69.3% | 71.1% | 64.9% | 74.8% |
| R&D | $12.8M | $18.6M | $16.0M | $10.9M | $38.3M | $18.6M | $29.7M | $56.1M |
| Operating income | $46.3M | $55.1M | $69.3M | $71.8M | $10.4M | $25.8M | $46.8M | $53.8M |
| EBITDA | $54.8M | $67.2M | $82.0M | $83.1M | $41.1M | $28.8M | $104.9M | $42.7M |
| Net income | $37.4M | $42.4M | $62.2M | $45.0M | $12.5M | $14.6M | $17.5M | −$8.5M |
| Net margin | 21.8% | 19.5% | 26.7% | 17.3% | 4.8% | 4.9% | 3.7% | -2.4% |
| EPS (diluted) | 0.19 | 0.21 | 0.30 | 0.22 | 0.06 | 0.07 | 0.08 | -0.04 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ABCM.
No tracked institution reports a position in ABCM as of their last filing.
No one on the platform has traded ABCM yet.
| $5.3B |
| — |
| MRTXMirati Therapeutics, Inc. | $58.70 | -0.17% | $4.1B | — |
| OPTOpthea Limited | $3.41 | +1.49% | $4.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ABCM trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $23.99 Vol: 7.43M.
View on StockTwits ↗$ABCM $DHR Danaher-Abcam deal approved by High Court of Justice of England and Wales Abcam (ABCM) entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (DHR) for $24 per share in cash, to be implemented by way of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006. The circular in relation to the Scheme was published or made available to Scheme Shareholders on October 5, 2023. Abcam announced announce that the Court has today issued the Court Order sanctioning the Scheme. Closing of the Transaction will occur and the Scheme will become effective upon the Court Order being delivered to the Registrar of Companies, which is expected to occur on December 6, 2023, as previously announced. The last day of trading in Abcam ADSs on Nasdaq is expected to be December 5, 2023, with trading in Abcam ADSs on Nasdaq being suspended by 8.00 a.m. ET on December 6, 2023.
View on StockTwits ↗Signal alert: $ABCM - Double Top https://stockinvest.us/l/U8omaNUYYj
View on StockTwits ↗$MCOM $ABCM Analyst price target for next week..🚀 amazon-stock-trading-welcome-trader.social-networking.me
View on StockTwits ↗$ABCM, $ROST, $GAP, $LI and $KOLD are gapping up today. https://www.chartmill.com/stock/stock-screener?v=3&f=s_gup,p_pg10,v1_50b500,exch_us&utm_source=Gap_Up&utm_medium=stocktwits&utm_campaign=screen
View on StockTwits ↗Abcam plc Files SEC Form 6-K $ABCM https://www.marketbeat.com/stocks/NASDAQ/ABCM/sec-filings/
View on StockTwits ↗$ABCM $DHR Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023 https://www.stocktitan.net/news/ABCM/abcam-acquisition-by-danaher-has-received-all-identified-clearances-9m93598xwyet.html
View on StockTwits ↗Signal alert: $ABCM - Double Top https://stockinvest.us/l/ZoKR43TYK1
View on StockTwits ↗🚨 Exclusive Look into Maverick Capital's Trades! 💹 301 stocks valued at $4.42 Billion. Top Buys: $PM, $BABA, $UNP, $STX, and $ABCM https://tickertracker.io/articles/d6kjogv531-lee-ainslie-s-q3-2023-portfolio-holdings-reveal-260-million-decrease-understanding-the-strategy-behind-the-adjustments
View on StockTwits ↗$ABCM | Danaher/Abcam: Balanced Risk/Return "Shareholders of Abcam approve scheme resolutions, with a $24/share cash offer from Danaher Corp expected to close mid-2024. Balanced risk/reward with a 3.21%/6.21% spread." - Jesus Rodriguez Aguilar Key Points: * Shareholders of Cambridge (UK)-based Abcam (ABCM US) followed Glass Lewis and ISS recommendations and approved (>84%) the scheme resolutions at both the Court Meeting and the GM. * The $24/share cash offer represents 10x EV/Fwd Revenue, 25x EV/Fwd NTM EBITDA. Danaher Corp (DHR US) and Abcam have guided that the transaction is expected to close by mid-2024. * Spread is 3.21%/6.21% (gross/annualised, assuming settlement by 30 May). From the current levels, I see a balanced risk/reward. Read more: https://www.smartkarma.com/insights/danaher-abcam-balanced-risk-return
View on StockTwits ↗Signal alert: $ABCM - Double Top https://stockinvest.us/l/QmvYlIo2Cr
View on StockTwits ↗Signal alert: $ABCM - Double Top https://stockinvest.us/l/g7cG76PYcU
View on StockTwits ↗$ABCM $DHR Shareholders of Abcam Approve Proposed Acquisition by Danaher https://www.stocktitan.net/news/ABCM/shareholders-of-abcam-approve-proposed-acquisition-by-dpldb4el24ly.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.